Isabelle Rouquette

5.9k total citations · 1 hit paper
85 papers, 2.8k citations indexed

About

Isabelle Rouquette is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Isabelle Rouquette has authored 85 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 23 papers in Surgery. Recurrent topics in Isabelle Rouquette's work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Diagnosis and Treatment (14 papers) and Lung Cancer Research Studies (13 papers). Isabelle Rouquette is often cited by papers focused on Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Diagnosis and Treatment (14 papers) and Lung Cancer Research Studies (13 papers). Isabelle Rouquette collaborates with scholars based in France, United States and Germany. Isabelle Rouquette's co-authors include Julien Mazières, Bélaïd Bouhemad, Silvia Mongodi, Gabriele Via, Denis Moro‐Sibilot, Michèle Beau‐Faller, Julie Milia, Marie Wislez, Sylvie Lantuéjoul and Benoît Lepage and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Isabelle Rouquette

79 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives

2013 489 citations Julien Mazières, Benoît Lepage et al. profile →

Peers

Countries citing papers authored by Isabelle Rouquette

Since Specialization

Citations

This map shows the geographic impact of Isabelle Rouquette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Rouquette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Rouquette more than expected).

Fields of papers citing papers by Isabelle Rouquette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Rouquette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Rouquette. The network helps show where Isabelle Rouquette may publish in the future.

Co-authorship network of co-authors of Isabelle Rouquette

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Rouquette. A scholar is included among the top collaborators of Isabelle Rouquette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Rouquette. Isabelle Rouquette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study 2020 ·European Journal of Cancer ·Thierry Jo Molina, (unknown), Lara Chalabreysse, Vincent de Montpréville, A. De Muret, Romain Dubois, Véronique Hofman, Sylvie Lantuéjoul, (unknown), Audrey Mansuet‐Lupo, Marie Parrens, Nicolas Piton, Isabelle Rouquette, Véronique Secq, Nicolas Girard, Alexander Marx, Benjamin Besse	9
2	Inequity in access to personalized medicine in France: Evidences from analysis of geo variations in the access to molecular profiling among advanced non-small-cell lung cancer patients: Results from the IFCT Biomarkers France Study 2020 ·PLoS ONE ·(unknown), William B. Weeks, L’Houcine Ouafik, Isabelle Rouquette, Michèle Beau‐Faller, Antoinette Lemoine, Pierre‐Paul Bringuier, Anne‐Gaëlle Le Corroller, Fabrice Barlési, Bruno Ventelou	8
3	Ultra-sensitive EGFR T790M Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring EGFR del19 Mutations and Treated with First-generation TKIs 2019 ·Clinical Cancer Research ·Julie A. Vendrell, Julien Mazières, (unknown), Isabelle Rouquette, Xavier Quantin, Jean-Louis Pujol, Benoît Roch, (unknown), Sylvain Godreuil, Étienne Coyaud, Pierre Brousset, Jérôme Solassol	28
4	P2.09-17 Real-World Concordance Across Pathologists for PD-L1 Scoring in Non-Small Cell Lung Cancer: Results from a Large Nationwide Initiative 2019 ·Journal of Thoracic Oncology ·Julien Adam, Véronique Hofman, Audrey Mansuet‐Lupo, Isabelle Rouquette, (unknown), Cécile Badoual, Hugues Bégueret, Marie‐Christine Copin, Diane Damotte, Claire Danel, Fabien Forest, S. Garcia, Laure Gibault, Frédérique Penault‐Llorca, Sylvie Lantuéjoul, Aurélie Cazes, Nolwenn Le Stang	7
5	Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer 2018 ·Annals of Oncology ·Julien Adam, Nolwenn Le Stang, Isabelle Rouquette, Aurélie Cazes, Cécile Badoual, (unknown), (unknown), Claire Danel, Francesca Damiola, Diane Damotte, Frédérique Penault‐Llorca, Sylvie Lantuéjoul	171
6	High-throughput detection of clinically targetable alterations using next-generation sequencing 2017 ·Oncotarget ·Julie A. Vendrell, David Grand, Isabelle Rouquette, Valérie Costes, (unknown), Janick Sèlves, (unknown), (unknown), Pierre Brousset, Jérôme Solassol	12
7	Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non–Small-cell Lung Cancer: A Phase I Study 2017 ·Clinical Lung Cancer ·Carole Massabeau, Jonathan Khalifa, Thomas Filleron, A. Modesto, L. Bigay-Gamé, Gavin Plat, Lawrence Dierickx, R. Aziza, Isabelle Rouquette, Carlos Gomez‐Roca, (unknown), Jean‐Pierre Delord, Christine Toulas, Pascale Olivier, Étienne Chatelut, Julien Mazières, Elizabeth Cohen‐Jonathan Moyal	21
8	Clinical and biological characteristics of non-small cell lung cancer (NSCLC) harbouring EGFR mutation: Results of the nationwide programme of the French Cooperative Thoracic Intergroup (IFCT) 2016 ·Annals of Oncology ·Charlotte Leduc, Hélène Blons, Benjamin Besse, J.P. Merlio, D. Debieuvre, Antoinette Lemoine, I. Monnet, Damien Pouessel, P. P. Bringuier, M. Poudenx, Isabelle Rouquette, F. Vaylet, Franck Morin, Alexandra Langlais, Élisabeth Quoix, Gérard Zalcman, Denis Moro‐Sibilot, J. Cadranel, Michèle Beau‐Faller, Fabrice Barlési	2
9	Pathological central review of 400 thymic epithelial tumors (TET): The national network RYTHMIC experience 2016 ·Annals of Oncology ·Thierry Jo Molina, (unknown), Lara Chalabreysse, Vincent de Montpréville, A. De Muret, Véronique Hofman, Sylvie Lantuéjoul, Marie Parrens, Isabelle Rouquette, Véronique Secq, Nadine Girard, Alexander Marx, Benjamin Besse	4
10	High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets 2015 ·Annals of Oncology ·Vincent Fallet, Raphaël Saffroy, Nicolas Girard, Julien Mazières, Sylvie Lantuéjoul, (unknown), Isabelle Rouquette, F. Thivolet-Béjui, Mony Ung, Virginie Poulot, (unknown), Denis Moro‐Sibilot, Martine Antoine, Jacques Cadranel, Antoinette Lemoine, Marie Wislez	74
11	RhoB Determines Tumor Aggressiveness in a Murine EGFRL858R-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer 2014 ·Clinical Cancer Research ·Olivier Calvayrac, Anne Pradines, Isabelle Raymond‐Letron, Isabelle Rouquette, Emilie Bousquet, Valérie Lauwers‐Cancès, Thomas Filleron, J. Cadranel, Michèle Beau‐Faller, (unknown), Julie Milia, Gilles Favre, Julien Mazières	18
12	Alternative Processing of the U2 Small Nuclear RNA Produces a 19–22nt Fragment with Relevance for the Detection of Non-Small Cell Lung Cancer in Human Serum 2013 ·PLoS ONE ·Julien Mazières, (unknown), Olivier Delfour, (unknown), Isabelle Rouquette, Marie‐Bernadette Delisle, Grégoire Prévôt, R. Escamilla, A. Didier, David H. Persing, (unknown), Bernard Michot	32
13	An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial 2012 ·Clinical Cancer Research ·Florence de Fraipont, Guénaëlle Levallet, Christian Créveuil, Emmanuel Bergot, Michèle Beau‐Faller, Mounia Mounawar, Nicolas Richard, Martine Antoine, Isabelle Rouquette, Marie‐Christine Favrot, D. Debieuvre, Denis Braun, Virginie Westeel, Élisabeth Quoix, Élisabeth Brambilla, Pierre Hainaut, Denis Moro‐Sibilot, Franck Morin, B. Milleron, Gérard Zalcman	46
14	High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway 2012 ·Molecular Cancer Therapeutics ·Guénaëlle Levallet, Emmanuel Bergot, Martine Antoine, Christian Créveuil, Adriana O. Santos, (unknown), Florence de Fraipont, Élisabeth Brambilla, Jérôme Levallet, Franck Morin, Virginie Westeel, Marie Wislez, Élisabeth Quoix, D. Debieuvre, Fatéméh Dubois, Isabelle Rouquette, Jean-Louis Pujol, Denis Moro‐Sibilot, Jacques Camonis, Gérard Zalcman	74
15	DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients 2012 ·Oncogenesis ·(unknown), Isabelle Rouquette, Benoît Lepage, Naïma Oumouhou, Marie Walschaerts, (unknown), (unknown), (unknown), L. Brouchet, Marie Bernadette Delisle, Julien Mazières, Jean‐Sèbastien Hoffmann, Philippe Pasero, Christophe Cazaux	92
16	Characteristics of lung cancer in women: Importance of hormonal and growth factors 2011 ·Lung Cancer ·Isabelle Rouquette, Valérie Lauwers‐Cancès, (unknown), L. Brouchet, Julie Milia, Yvan Nicaise, Julie Laurent, Marie‐Bernadette Delisle, Gilles Favre, A. Didier, Julien Mazières	37
17	The Prognostic Significance of Lymphovascular Invasion on Biopsy Specimens in Lung Cancer Treated With Definitive Chemoradiotherapy 2011 ·Clinical Lung Cancer ·Carole Massabeau, Thomas Filleron, (unknown), Isabelle Rouquette, Jean‐Marc Bachaud, (unknown), Marie‐Bernadette Delisle, Christine Toulas, Julien Mazières, Elizabeth Cohen‐Jonathan Moyal	4
18	Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma 2011 ·Annals of Oncology ·Paul Hofman, Marius Ilié, Véronique Hofman, S. Roux, A. Valent, Alain Bernheim, Marco Alifano, François Leroy-Ladurie, F. Vaylet, Isabelle Rouquette, Pierre Validire, Michèle Beau‐Faller, (unknown), Jean‐Charles Soria, P Fouret	48
19	Adenoid cystic carcinoma of the lung: Interest of 18FDG PET/CT in the management of an atypical presentation 2007 ·Lung Cancer ·(unknown), Isabelle Rouquette, F. Courbon, V. Chabbert, Philippe Rochaix, Grégoire Prévôt, Sophie Laroumagne, L. Têtu, A. Didier, Julien Mazières	11
20	Diagnostic value of bronchoscopy, CT and transbronchial biopsies in diffuse pulmonary lymphangiomatosis: case report and review of the literature 2005 ·Clinical Radiology ·(unknown), Julien Mazières, Isabelle Rouquette, Marie Mittaine, (unknown), A. Didier, Marcel Dahan, (unknown), V. Chabbert	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact